| Literature DB >> 25422738 |
Samia Younes1, Yousra Cherif1, Mouna Aissi2, Wafa Alaya1, Olfa Berriche1, Amel Boughammoura2, Mahbouba Frih-Ayed2, Baha Zantour1, Mohamed Habib Sfar1.
Abstract
BACKGROUND: Non-ketotic hyperglycemia (NKHG) may increase the probability of seizures and movement disorders.Entities:
Keywords: Chorea-Ballismus; Hyperglycemia Without Ketosis; Movement Disorder; Non-Ketotic Hyperglycemia; Seizures
Year: 2014 PMID: 25422738 PMCID: PMC4240936
Source DB: PubMed Journal: Iran J Neurol ISSN: 2008-384X
Clinical and paraclinical details of 14 elderly patients with seizures and movement disorders related to non-ketotic hyperglycemia on admission and discharge
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||||||
| 76/F | 14 | PMS in right hemi-body | Memory disturbance | 31.80 | 320 | 7.54 | 133/3.2 | 53 | CSCA | - | ND/ND | Insulin | 1 | No recurrence |
| 77/M | 20 | GTCS | N | 17.70 | 319 | ND | 145/3.7 | 70 | N | - | N/ND | Insulin, valproate | 1 | Recurrent seizures |
| 73/F | 7 | PMS in right hemi-face | Coma right hemiparesis | 20.40 | 313 | ND | 132/4.2 | 69 | N | - | ND/fronto-temporal epileptogenic area | Insulin, valproate | 1 | No recurrence |
| 71/F | 5 | GTCS→PSE | N | 32.00 | 328 | 7.47 | 135/4.1 | 88 | N | - | N/ND | Insulin | 4 | Recurrent seizures |
| 71/M | 7 | GTCS | Left hemiparesis | 19.05 | 309 | ND | 138/3.7 | 127 | LS | - | N/ND | Insulin, clonazepam | 3 | Recurrent seizures |
| 80/F | 15 | Right versive | Right hemiparesis | 27.00 | 320 | 7.44 | 138/4.1 | 153 | LS | Frontal hygroma | ND/ND | Insulin | 2 | No recurrence |
| 79/M | 5 | PMS on right upper limb secondarily GTCS | N | 20.85 | 319 | 7.42 | 133/4.5 | 160 | CSCA | - | N/ND | Insulin | 1 | No recurrence |
| 76/F | 12 | Left hemiballism | N | 28.80 | 324 | 7.33 | 132/5 | 145 | LS | CSCA leukoaraiosis ancient left pontine stroke | ND/ND | Insulin | 4 | No recurrence |
| 78/F | 10 | Left hemichorea | N | 19.50 | 318 | ND | 133/4.5 | 158 | CSCA, leukoaraiosis | - | N/ND | Insulin | 4 | No recurrence |
| 72/F | PSE | N | 14.54 | 295.34 | ND | 140/3.8 | 65 | CSCA | - | N/ND | Insulin, Valproate | 2 | No recurrence | |
| 68/F | PMS | N | 13.00 | 305 | ND | 139/4.1 | 79 | N | - | ND/ND | Insulin | 1 | No recurrence | |
| 72/M | GTCS | N | 18.60 | 323 | ND | 138/4.2 | 75 | N | - | N/ND | Insulin | 3 | No recurrence | |
| 77/M | GTCS | N | 15.08 | 302.28 | ND | 135/4.4 | 82 | N | CSCA | N/ND | Insulin | 2 | No recurrence | |
| 75/M | GTCS | N | 9.28 | 315 | ND | 137/3.7 | 69 | N | - | N/ND | Insulin, Valproate | 1 | No recurrence | |
MD: Mellitus diabetes; CT: Computed tomography; MRI: Magnetic resonance imaging; CSCA: Cortico-subcortical atrophy; PMS: Partial motor seizures; GTCS: Generalized tonic-clonic seizures
N: Normal; PSE: Partial status epilepticus, LS: Lacunar stroke, EEG: Electroencephalogram, ND: Not done